Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men

1. Bhasin, S, Brito, JP, Cunningham, GR, et al. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;103(5):1715–1744.
Google Scholar | Crossref2. Shackleford, DM, Faassen, WA, Houwing, N, et al. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther. 2003;306(3):925–933.
Google Scholar | Crossref | Medline3. DelConte, A, Patel, MV, Papangkorn, K, et al. Novel oral testosterone therapy (TLANDO) safely restores testosterone to eugonadal levels with fixed dose treatment. J Endo Soc. 2020;4(suppl 1):SAT–052.
Google Scholar4. Pastuszak, AW, Gomez, LP, Scovell, JM, Khera, M, Lamb, DJ, Lipshultz, LI. Comparison of the effects of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and prostate-specific antigen. Sex Med. 2015;3(3):165–173.
Google Scholar | Crossref | Medline5. Alpert, B . Validation of the Tiba medical Ambulo 2400 ambulatory blood pressure monitor to the ISO Standard and BHS protocol. Blood Press Monit. 2010;15(5):275–277.
Google Scholar | Crossref | Medline6. Garnett, C, Johannesen, L, McDowell, TY. Redefining blood pressure assessment—the role of the ambulatory blood pressure monitoring study for drug safety. Clin Pharmacol Ther. 2020;107(1):147–153.
Google Scholar | Crossref | Medline7. Harrison, NR, Sager, PT, Krucoff, MW, Weber, MA, White, WB. Methodological and regulatory considerations for updated guidance on the pressor effects of drugs. Ther Innov Regul Sci. 2020;54(6)1473-1476.
Google Scholar | Crossref | Medline8. Mancia, G, Omboni, S, Parati, G, Ravogli, A, Villani, A, Zanchetti, A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens. 1995;8(3):311–315.
Google Scholar | Crossref | Medline9. Kennedy, BJ . Stimulation of erythropoiesis by androgenic hormones. Ann Intern Med. 1962;57(4):917–936.
Google Scholar | Crossref | Medline10. Saad, F, Aversa, A, Isidori, AM, Zafalon, L, Zitzman, M, Gooren, L. Onset of effects of testosterone treatment and time span until maximal effects are achieved. Eur J Endocrinol. 2011;165(5):675–685.
Google Scholar | Crossref | Medline | ISI11. Dhindsa, S, Ghanim, H, Batra, M, et al. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes. Clin Endocrinol (Oxf). 2016;85(5):772–780.
Google Scholar | Crossref | Medline12. Lewington, S, Clarke, R, Qizilbash, N, Peto, R, Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913.
Google Scholar | Crossref | Medline | ISI13. Boden, WE, Miller, MG, McBride, R, et al. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. Am Heart J. 2020;224:65–76.
Google Scholar | Crossref | Medline14. Sharma, R, Oni, OA, Gupta, K, et al. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J. 2015;36(40):2706–2715.
Google Scholar | Crossref | Medline15. Traish, AM, Haider, A, Haider, KS, Doros, G, Saad, F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther. 2017;22(5):414–433.
Google Scholar | SAGE Journals | ISI16. Swerdloff, RS, Wang, C, White, WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515–2531. doi:10.1210/clinem/dgaa238
Google Scholar | Crossref17. Gittleman, M, Jaffe, S, Kaminetsky, JC. Safety of a new subcutaneous testosterone enanthate auto-injector: results of a 26-week study. J Sex Med. 2019;16(11):1741–1748.
Google Scholar | Crossref | Medline18. Mansoor, GA, McCabe, EJ, White, WB. Long-term reproducibility of ambulatory blood pressure. J Hypertens. 1994;12(6):703–708.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif